The model considers adsorption, etching/desorption, lattice incor

The model considers adsorption, etching/desorption, lattice incorporation, and surface migration along and across the dimer rows. The reaction rates for these processes are re-evaluated in detail and their effect upon

the predicted growth rates and morphology are described. We find that for standard CVD diamond conditions, etching of sp(3) carbon species from the growing surface is negligible. Surface migration occurs rapidly, but is mostly limited to CH(2) species oscillating back and forth between two adjacent radical sites. Despite the average number of migration hops being in the thousands, the average surface diffusion length Dibutyryl-cAMP order for a surface species-before it either adds to the diamond lattice or is removed back to the gas phase-is <2 sites. beta-scission helps to smooth the surface, but is only a relatively minor process removing <2% of adsorbed species. At low substrate temperature, migration is negligible with film growth being dominated by direct adsorption (Eley-Rideal) processes. The resulting films are rough and spiky, reminiscent of amorphous carbon.

With increasing substrate temperature migration increases in significance until for temperatures >1000 K migration becomes the major process by which the surface becomes smoother. Langmuir-Hinshelwood processes are now the dominant growth mechanism, although 30% of growth still occurs via direct adsorption. (C) 2010 American Institute of Physics. [doi: 10.1063/1.3437647]“
“Background: Low-birth-weight infants may have

impaired zinc status, but little is known about the effect Ruboxistaurin TGF-beta/Smad inhibitor of zinc supplementation.

Objective: The objective was to investigate the effect of daily zinc supplementation on morbidity and anthropometric status in hospital-born, low-birth-weight infants.

Design: In a double-blind, randomized, placebo-controlled trial, 2052 hospital-born term infants with a birth weight <= 2500 g were randomly assigned to receive zinc or placebo. The zinc group received elemental zinc: 5 mg/d for those infants between ages 2 wk and 6 mo and 10 mg/d for those infants aged >6 mo. All-cause hospitalizations, prevalence of diarrhea, acute lower respiratory tract infections, visits to health care providers, weights, and lengths were ascertained at C59 3, 6, 9, and 12 mo of age.

Results: The supplement was consumed for >85% of the follow-up period. Mean plasma zinc at 12 mo of age was higher in the zinc group (100.2 mu g/dL) than in the control group (73.3 mu g/dL) (difference in means: 26.9; 95% CI: 19.6, 34.2). The 24-h and 7-d prevalence of diarrhea and acute lower respiratory tract infections was similar at 3, 6, 9, and 12 mo. Care-seeking for illness was significantly lower in the zinc group (difference in proportions: -5.7; 95% CI: -9.9, -1.4; P < 0.05) at 9 mo. The numbers of hospitalizations, weights, and lengths were all similar at all 4 assessments.

Comments are closed.